Abstract

<h3>To the Editor:—</h3> Many investigators<sup>1-5</sup>have shown that the risk of a clinical episode of coronary artery disease is closely correlated with serum cholesterol levels. These epidemiologic studies show that the hypercholesterolemic population has a three to five times greater risk of coronary heart disease (CHD) than the normocholesterolemic population. Recognition of this important correlation has generated efforts to screen large population groups for elevated cholesterol levels. It is an interesting observation that physicians and their families are seldom included in local health programs. Because of this it seemed particularly appropriate to carry out a cholesterol-screening program exclusively for physicians and their guests at medical conventions. Accordingly, Flint Laboratories carried out such a program at eight medical meetings, beginning with the American Medical Association convention, 1967, and ending with the AMA convention, 1968. The screening program included 2,973 individuals, who were selected for no reason other than their presence

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.